Early chemotherapy and concurrent radio-chemotherapy in high grade glioma

Journal of Neuro-Oncology

Volumn 30, Issue 3, 1996, Pages 247-255

  Brandes, Alba Ariela ^a,b   Rigon, Alberto ^a   Zampieri, Paolo ^a   Scelzi, Elvira ^a   Amistà, Pietro ^a   Berti, Franco ^a   Rotilio, Antonio ^a   Gardiman, Marina ^a   Fiorentino, Mario Vincenzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Carboplatin; Central nervous system tumors; Concurrent radio chemotherapy; Early chemotherapy; Teniposide

Indexed keywords

CARBOPLATIN; CARMUSTINE; TENIPOSIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; INTRACRANIAL HYPERTENSION; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; NEUROTOXICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0029973566     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00177276     Document Type: Article

References (30)

1. Brandes A, Soesan M, Fiorentino M: Medical treatment in high grade malignant gliomas in adults: an overview. Anti cancer Research 11: 719-728, 1991
2. Levin VA, Silver P, Hannigan J et al.: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, Procarbazine and Vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncology Biol Phys 18: 321-324, 1990
3. Shapiro JR, Mehta BP, Fiola M et al.: A minor sub population of cells in freshly resected malignant gliomas is BCNU-resistant, secretes PDGF-like peptides and becomes the dominant population after BCNU treatment. Abs Eight International Conference on Brain Tumor Research and Therapy, Lausanne, S30, 109, 1989
4. Vokes EE, Wechselbaum R: Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8: 911-934, 1990
5. EORTC Brain Tumor Group: Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. Eur J Cancer 21(5): 568-572, 1991
6. Yung WK, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 9: 860, 1991
7. Durand RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep 71: 673-679, 1987
8. Spremulli E, Schulz JJ, Speckart VJ: Phase II study of VM-26 in adult malignancies. Cancer Treat Rep 64: 147, 1980
9. Jeremic B, Grujicic D, Jevremovic S: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 10: 1074-1077, 1992
10. Burger PC: Malignant astrocytic neoplasms: classification, pathology, anatomy and response to treatment. Semin Oncol 13(1): 16-26, 1986
11. Macdonald DR, Cascino TL, Clifford S: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
12. WHO Handbook for reporting results of cancer treatment. WHO offset publication N°48 Neoplasma 20: 37-46, 1980
13. Kaplan EL, Meier P: Non parametric estimation for incomplete observation. J Am Stat Assoc 53: 457-481, 1958
14. Coughlin CT, Richmond RC: Biologic and clinical developments of cisplatin combined with radiation: concepts: utility, projections for new trials, and the emergence of carboplatin. Seminars in oncol 16: 31-43, 1989
15. Doz F, Berens M, Doughery D et al.: Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. Journal of Neurooncology 11: 27-35, 1991
16. Walker RW, Cairncross JG, Posner JB: Cerebral herniation in patients receiving cisplatin. J of Neuro-Oncology 6:61-65, 1988
17. Wallner KE, Galicich JH, Krol G et al.: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405-1409, 1989
18. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980
19. Bonadonna G, Robustelli della Cuna G: Manuele di Oncologia Medica. Masson, Milan 1991, pp 506-509
20. Walker MD, Eben A, Hunt WE et al.: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333-343, 1978
21. Walker MD, Green SB, Byar DP et al.: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 303 (23): 1323-1329, 1980
22. Green SB, Byar DP, Walker MD et al.: Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67(2): 121-132, 1983
23. Deutsch M, Green SB, Strike T et al.: Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16: 1389-1396, 1989
24. Shapiro WR, Green SB, Burger PC et al.: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 71: 1-9, 1989
25. Shapiro WR, Green SB, Burger PC et al.: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992
26. Chang CH, Horton J, Schoenfeld D et al.: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant glioma. Cancer 52: 997-1007, 1983
27. Levin VA, Wara WM, Davis RL et al.: Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63: 218-223, 1985
28. Yung WKA, Janus TJ, Maor M et al.: Adjuvant chemotherapy with carmustine and cisplatin for pts with malignant gliomas. J Neuro-Oncol 12: 131-135, 1992
29. Cvitkovic FB, Haie-Meder C, Papadimitrakopoulou V et al.: Pilot study of 6 weeks of chemoradiotherapy with 5-FU and hydroxyuera in malignant glioma. J of Neuro-Oncol 15: 9-17, 1993
30. Lange OF, Haase KD, Scheef W: Simultaneous radio- and chemotherapy of inoperable brain tumors. Radiotherapy and Oncology 8: 309-314, 1987